These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11059832

  • 1. Optimization study on the formulation of roxithromycin dispersible tablet using experimental design.
    Weon KY, Lee KT, Seo SH.
    Arch Pharm Res; 2000 Oct; 23(5):507-12. PubMed ID: 11059832
    [Abstract] [Full Text] [Related]

  • 2. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z, Siddiqui A, Khan MA.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [Abstract] [Full Text] [Related]

  • 3. Formulation development and optimization of Ibuprofen tablets by direct compression method.
    Bushra R, Shoaib MH, Aslam N, Hashmat D, Ur-Rehman M.
    Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
    [Abstract] [Full Text] [Related]

  • 4. EFFECT OF FORMULATION AND PROCESS VARIABLES ON THE RELEASE, MECHANICAL AND MUCOADHESIVE PROPERTIES OF IBUPROFEN TABLET FORMULATIONS.
    Adetunji OA, Odeniyi MA, Itiola OA.
    Acta Pol Pharm; 2015 Apr; 72(2):357-65. PubMed ID: 26642687
    [Abstract] [Full Text] [Related]

  • 5. An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine.
    Mishra SM, Rohera BD.
    Pharm Dev Technol; 2017 Nov; 22(7):889-903. PubMed ID: 27346282
    [Abstract] [Full Text] [Related]

  • 6. Formulation design, characterization and optimization of cinitapride (1mg) immediate release tablets using direct compression technology.
    Bushra R, Rehman A, Ghayas S, Zafar F, Ali H, Shafiq Y, Khalid F, Khan MA, Hanif A, Mustapha O.
    Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2725-2731. PubMed ID: 30587486
    [Abstract] [Full Text] [Related]

  • 7. Factorial design of experiment for stability studies in the development of a tablet formulation.
    El-Banna HM, Ismail AA, Gadalla MA.
    Pharmazie; 1984 Mar; 39(3):163-5. PubMed ID: 6728887
    [Abstract] [Full Text] [Related]

  • 8. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design.
    Soroush H, Ghorbani-Bidkorbeh F, Mortazavi SA, Mehramizi A.
    Iran J Pharm Res; 2018 Mar; 17(4):1150-1163. PubMed ID: 30568675
    [Abstract] [Full Text] [Related]

  • 9. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
    Omar SM, AbdAlla FI, Abdelgawad NM.
    AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
    [Abstract] [Full Text] [Related]

  • 10. Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness.
    Alyami HS, Ibrahim MA, Alyami MH, Dahmash EZ, Almeanazel OT, Algahtani TS, Alanazi F, Alshora DH.
    Saudi Pharm J; 2021 May; 29(5):478-486. PubMed ID: 34135674
    [Abstract] [Full Text] [Related]

  • 11. Quality-by-design based development of fast dispersible nimodipine tablets: Formulation attributes and release kinetic assessment.
    Akhtar H, Raza Naqvi G, Zafar F, Ali H, Saeed R, Parveen S, Alam S.
    Pak J Pharm Sci; 2023 Mar; 36(2):547-556. PubMed ID: 37530164
    [Abstract] [Full Text] [Related]

  • 12. Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate.
    Taha EI, Samy AM, Kassem AA, Khan MA.
    Pharm Dev Technol; 2005 Mar; 10(3):363-70. PubMed ID: 16176016
    [Abstract] [Full Text] [Related]

  • 13. Optimization of minoxidil microemulsions using fractional factorial design approach.
    Jaipakdee N, Limpongsa E, Pongjanyakul T.
    Pharm Dev Technol; 2016 Mar; 21(1):86-97. PubMed ID: 25318551
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P, Martelli S, Wehrlé P.
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [Abstract] [Full Text] [Related]

  • 15. Factorial analysis of the binding properties of acetylated ginger starch in metronidazole tablet formulations.
    Bamiro OA, Duro-Emanuel AJ.
    Int J Pharm Investig; 2017 Jan; 7(1):18-24. PubMed ID: 28405575
    [Abstract] [Full Text] [Related]

  • 16. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
    Chudiwal VS, Shahi S, Chudiwal S.
    Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
    [Abstract] [Full Text] [Related]

  • 17. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design.
    Prakobvaitayakit M, Nimmannit U.
    AAPS PharmSciTech; 2003 Dec 31; 4(4):E71. PubMed ID: 15198566
    [Abstract] [Full Text] [Related]

  • 18. Development and Method Validation of Design of Experiments-Optimized Tablet Formulation for Simultaneous Detection of Exemestane and Everolimus.
    Kumar A, Kurmi BD, Singh D.
    Assay Drug Dev Technol; 2023 Dec 31; 21(6):273-287. PubMed ID: 37682343
    [Abstract] [Full Text] [Related]

  • 19. Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.
    Farooqi S, Yousuf RI, Shoaib MH, Ahmed K, Ansar S, Husain T.
    Drug Des Devel Ther; 2020 Dec 31; 14():5217-5234. PubMed ID: 33273807
    [Abstract] [Full Text] [Related]

  • 20. Systematic Development and Optimization of an in-situ Gelling System for Moxifloxacin Ocular Nanosuspension using High-pressure Homogenization with an Improved Encapsulation Efficiency.
    Khurana LK, Singh R, Singh H, Sharma M.
    Curr Pharm Des; 2018 Dec 31; 24(13):1434-1445. PubMed ID: 29611480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.